CIK 0001385818 · Non-accelerated filer<br>Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 470883144
- Phone
- (720) 437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy Director bought 33,333 shares at $1.50 ($50,000)
- 4 Open-market buy Chief Financial Officer bought 66,666 shares at $1.50 ($99,999)
- 4 Open-market buy Chief Operating Officer bought 166,666 shares at $1.50 ($249,999)
- 4 Open-market buy Chief Executive Officer bought 166,666 shares at $1.50 ($249,999)
- 8-K Event Material agreement · Other events
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- FWP Offering Free Writing Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
Page 35 of 46 · 907 filings